학술논문

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
Document Type
Article
Source
Neurology® Neuroimmunology & Neuroinflammation; Mar2023, Vol. 10 Issue 2, p1-10, 10p
Subject
Language
ISSN
23327812